Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B

Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B

(2012) N. Gara et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients

(2011) Yu Jin Kim et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients

(2011) Spilios Manolakopoulos et al.   LIVER INTERNATIONAL

Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients

(2010) Ryan D. Cooper et al.   CLINICAL INFECTIOUS DISEASES

Antiviral resistance and hepatitis B therapy

(2010) Marc G. Ghany et al.   HEPATOLOGY

Efficacy and Pharmacokinetics of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B and Renal Impairment

(2010) Mitchell L. Shiffman MD et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy

(2010) Mark A. Perazella   KIDNEY INTERNATIONAL

Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil

(2009) Nghi B. Ha et al.   HEPATOLOGY

Combination of Lamivudine and adefovir therapy in HBeAg-positive chronic hepatitis B patients with poor response to adefovir monotherapy

(2009) L.-C. Wang et al.   JOURNAL OF VIRAL HEPATITIS

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

(2008) Patrick Marcellin et al.   HEPATOLOGY